2018 annual financial data
Denali Therapeutics 2018 Operating cash flow margin
Direct answer
Operating cash flow margin was 38.8%.
Operating income was -46,372,000 USD and net income was -36,240,000 USD.
Operating cash flow was 50,116,000 USD.
Get free Denali Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 129,160,000 USD
- Operating income
- -46,372,000 USD
- Net income
- -36,240,000 USD
- Operating cash flow
- 50,116,000 USD